Neuphoria Therapeutics (NEUP) Other Non-Current Assets (2020 - 2025)
Neuphoria Therapeutics (NEUP) reported Other Non-Current Assets of $79,647 for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 7.7% from $73,982 a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Other Non-Current Assets (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Neuphoria Therapeutics posted Other Non-Current Assets of $77,945, down 1.1% from FY2024.
- By fiscal year, Other Non-Current Assets came in at $78,826 in FY2024 (-0.1%) and $78,897 in FY2023.
- The fiscal Q2 2026 figure ranks as the highest quarterly Other Non-Current Assets since fiscal Q1 2025.
- Year over year, Other Non-Current Assets gained in 1 of the last six quarters, with an average decline of 1.9%.
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $78,564 (Q1 2026), $77,945 (Q4 2025) and $74,732 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Neuphoria Therapeutics | 335.34 Mn | 260.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 79,647.00 |
| Sep 30, 2025 | 78,564.00 |
| Jun 30, 2025 | 77,945.00 |
| Mar 31, 2025 | 74,732.00 |
| Dec 31, 2024 | 73,982.00 |
| Sep 30, 2024 | 82,491.00 |
| Jun 30, 2024 | 78,826.00 |
| Mar 31, 2024 | 77,731.00 |
| Dec 31, 2023 | 81,396.00 |
| Jun 30, 2023 | 78,897.00 |
| Jun 30, 2022 | 1.01 Mn |
| Jun 30, 2021 | 648,897.04 |
| Jun 30, 2020 | 58,490.24 |
API Access
Neuphoria Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();